机译:S-1加顺铂同时化学放疗在无法切除的头颈部局部晚期鳞状细胞癌患者中进行的II期临床试验:日本临床肿瘤学小组研究(JCOG0706)
1Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, Tokyo 2Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba 3Department of Medical Oncology, Kobe University Hospital, Kobe 4Department of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Chiba 5Department of Radiology, Tokyo Women's Medical University Hospital, Tokyo 6Department of Otolaryngology, National Hospital Organization Tokyo Medical Center 7Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan;
机译:S-1加顺铂同时放化疗在无法切除的局部晚期头颈部鳞状细胞癌患者中进行的II期临床试验:日本临床肿瘤学小组研究(JCOG0706)。
机译:S-1加顺铂进行放化疗的II期临床试验无法切除的局部晚期头颈癌(JCOG0706)
机译:S-1加顺铂联合化疗治疗无法切除的局部晚期头颈部鳞状细胞癌的I期临床试验。
机译:CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
机译:EGFRvIII在头颈部鳞状细胞癌中的表达和信号传导。
机译:S-1加顺铂放化疗治疗无法切除的局部晚期头颈癌的II期临床试验(JCOG0706)
机译:同期试验与S-1加顺铂的同步化学疗法在头部和颈部局部晚期鳞状细胞癌的患者中:日本临床肿瘤群体研究(JCOG0706)